Quick answers
- What is Prexxartan?
- Prexxartan is a brand name of Valsartan, a prescription medicine. The FDA NDC Directory lists 1 Prexxartan product in 1 strength and form.
- Who makes Prexxartan?
- Carmel Biosciences holds the FDA application for Prexxartan (NDA209139, approved December 19, 2017).
- Is there a generic or store brand of Prexxartan?
- Yes. The FDA NDC Directory lists 3 other products with the same active ingredients, strength and form as a Prexxartan product, 3 of them generic. Ask your pharmacist whether one is right for you.
- Has Prexxartan been recalled?
- No recall linked to Prexxartan products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Prexxartan is
Each Prexxartan product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Valsartan · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| valsartan 4 mg/mL solution (oral) | Prexxartan | 3 products, 3 companies | — |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Valsartan →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA209139 | Carmel Biosciences | December 19, 2017 | 1 |
Companies that list Prexxartan
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Prexxartan products.
- AptaPharma Inc.1 product
Recalls
No recall linked to Prexxartan products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.